10893282

Source:http://linkedlifedata.com/resource/pubmed/id/10893282

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0030705, umls-concept:C0034656, umls-concept:C0210630, umls-concept:C0332173, umls-concept:C1707455, umls-concept:C2603343
pubmed:issue	13
pubmed:dateCreated	2000-7-27
pubmed:abstractText	To explore the use of SD/01 (a polyethylene glycol-conjugated filgrastim shown in preclinical studies to have a prolonged half-life) in patients with chemotherapy-induced neutropenia.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/M01RR30
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Filgrastim, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobins, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0732-183X
pubmed:author	pubmed-author:BjurstromTT, pubmed-author:BlackwellSS, pubmed-author:CrawfordJJ, pubmed-author:GardnerSS, pubmed-author:GarstJJ, pubmed-author:JohnstonEE, pubmed-author:LockbaumPP, pubmed-author:Miller-MessanaM AMA, pubmed-author:RoskosLL, pubmed-author:SchwabGG, pubmed-author:ShoemakerDD, pubmed-author:YangB BBB
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2522-8
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:10893282-Aged, pubmed-meshheading:10893282-Antigens, CD34, pubmed-meshheading:10893282-Antineoplastic Agents, pubmed-meshheading:10893282-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:10893282-Dose-Response Relationship, Drug, pubmed-meshheading:10893282-Female, pubmed-meshheading:10893282-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:10893282-Hematopoietic Stem Cell Mobilization, pubmed-meshheading:10893282-Hemoglobins, pubmed-meshheading:10893282-Humans, pubmed-meshheading:10893282-Leukocyte Count, pubmed-meshheading:10893282-Lung Neoplasms, pubmed-meshheading:10893282-Male, pubmed-meshheading:10893282-Middle Aged, pubmed-meshheading:10893282-Neutropenia, pubmed-meshheading:10893282-Neutrophils, pubmed-meshheading:10893282-Pilot Projects, pubmed-meshheading:10893282-Platelet Count, pubmed-meshheading:10893282-Polyethylene Glycols, pubmed-meshheading:10893282-Recombinant Proteins
pubmed:year	2000
pubmed:articleTitle	Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy.
pubmed:affiliation	Thoracic Oncology Program, Duke Comprehensive Cancer Center, Durham, NC 27710, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't